Insiders who reported open-market trades in the last 12 months at the companies Douglas H. Shulman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Larry Robbins - $352.74M in CVS purchases and sales in the last 12 months
Tilak Mandadi - $6.23M in CVS purchases and sales in the last 12 months
Micah R. Conrad - $1.52M in OMF purchases and sales in the last 12 months
Michael A. Hedlund - $315K in OMF purchases and sales in the last 12 months
Steven H. Nelson - $1K in CVS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Douglas H. Shulman is a corporate insider, tracked as Director of CVS HEALTH Corp (CVS). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Douglas H. Shulman last file a Form 4?
The most recent primary Form 4 on record is dated 15 May 2026, one of 12 filings going back to 2024.
Has Douglas H. Shulman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($5.51M) across all tracked filings.
Douglas H. Shulman is Director of CVS HEALTH Corp (CVS). 12 SEC Form 4 filings on record going back to 2024, most recently on 15 May 2026. Most recent open-market trade: sold $2.08M of OMF on 5 November 2025. Lifetime open-market sales: $5.51M.
Recent transactions
14
The latest 14 SEC Form 4 transactions reported by Douglas H. Shulman.
InsiderAlpha's records for Douglas H. Shulman go back to 2024: 12 primary Form 4 filings, an average of 4.0 per year. 3 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
